Kerx stock history

Sep 07, 2016 · Here's Why Keryx Biopharmaceuticals Plunged 44.3% in August KERX), a commercial-stage investors sold off the stock when the news hit the wires and have stayed down ever since. KERX - Keryx Biopharmaceuticals, Inc. Stock Prediction and ...

Logs contact history, stock ownership, and portfolio goals. Investor specialists access proprietary data sorts to reinforce client news flow, develop market  In fact, analysts had set their average first-year target for the stock at about $23. And there was every reason to believe Keryx would reach and break through that   Mar 7, 2014 We wanted to find out which stocks have done best since the onset of the Although the stock has responded in kind and then some, CalAmp's history may Much of the huge gain by Keryx (KERX) has come in the past 15  Find the perfect history books shelves stock photo. Huge collection, amazing choice, 100+ million high quality, affordable RF and RM images. No need to  Your Account · AutoShip Manager · Order History · Wishlist; Start SmartPaks Ship speed applies to in stock items, pending location. Does not include  Horse Electrolyte Supplements Comparison Chart. 100% Happiness Guarantee; Still have questions? See Q&A; Need more assistance? Contact us. turnout, and as specialized postsurgical nutritional support. Equine Joint Supplements Comparison Chart. 100% Happiness Guarantee; Still have questions?

KERX Market Cap History

Keryx Biopharmaceuticals - KERX - Stock Price & News | The ... Real time Keryx Biopharmaceuticals (KERX) stock price quote, stock graph, news & analysis. KERX Stock Price, Forecast & News (Keryx Biopharmaceuticals) Researching Keryx Biopharmaceuticals (NASDAQ:KERX) stock? View KERX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Johnson and Johnson (JNJ) has the following price history information. Looking back at JNJ historical stock prices for the last five trading days, on March 27, 2020, JNJ opened at $121.65, traded as high as $127.62 and as low as $120.58, and closed at $123.16. Trading volume was a total of 12.13M shares.

Keryx Biopharmaceuticals, Inc. (KERX) latest earnings report: revenue, EPS, surprise, history, news and analysis. Insider trading history of Holmes Scott A at Keryx ... The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Holmes Scott A since year 2005. The trader's CIK number is 1537670.At the time of the last reporting, Holmes Scott A was the Chief Accounting Officer of Keryx Biopharmaceuticals Inc .

KERX - Keryx Biopharmaceuticals, Inc. Stock Prediction and ...

KERX dividend history, yield, payout ratio, and stock fundamentals. See upcoming ex-dividends and access Dividata's ratings for Keryx Biopharma. KERX Stock Rating and Data | Keryx Biopharmaceuticals ... KERX stock rating and analysis - Keryx Biopharmaceuticals : a summary of key financial strength and profitability metrics. Keryx Biopharma PEG Ratio, KERX Stock PEG Chart History Keryx Biopharma PEG Ratio and Chart History - Get free financial information for KERX Stock with Stock Traders Daily. AKBA Akebia Therapeutics — Stock Price and ... - StockTwits

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tarnok Michael P. since year 2005. The trader's CIK number is 1413525.At the time of the last reporting, Tarnok Michael P. was the Director of Keryx Biopharmaceuticals Inc .

Company profile page for Keryx Biopharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information. Skip To Content. Keryx Biopharmaceuticals, Inc. - TheStreet - Stock Market

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tarnok Michael P. since year 2005. The trader's CIK number is 1413525.At the time of the last reporting, Tarnok Michael P. was the Director of Keryx Biopharmaceuticals Inc .